Bio-Rad Labs Inc. A Stock
Price
Target price
€230.90
€230.90
-1.520%
-3.5
-1.520%
€334.98
19.02.26 / Tradegate
WKN: 865406 / Symbol: BIO / Name: Bio Rad / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bio-Rad Labs Inc. A Stock
We can see a decrease in the price for Bio-Rad Labs Inc. A. Compared to yesterday it has lost -€3.500 (-1.520%).
Currently there is a rather positive sentiment for Bio-Rad Labs Inc. A with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 334 € shows a positive potential of 44.65% compared to the current price of 230.9 € for Bio-Rad Labs Inc. A.
For the coming years our community has positive and negative things to say abot the Bio-Rad Labs Inc. A stock. Criterium "Revenue growth" gathered the most positive votes but regarding "Revenue growth" there were negative voices in the community.
Pros and Cons of Bio-Rad Labs Inc. A in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Rad Labs Inc. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Rad Labs Inc. A | -1.520% | -6.707% | -13.585% | -14.734% | -10.469% | -48.905% | -56.434% |
| Neogen Corp. | 2.670% | 3.315% | 14.024% | -5.556% | 52.033% | - | - |
| Merit Medical Systems | 0.000% | 3.731% | -0.714% | -31.863% | -6.081% | 7.752% | 43.004% |
| Bio-Techne Corp. | 1.210% | -7.339% | -13.675% | -20.472% | 1.000% | -29.371% | - |
Comments
Bio-Rad Laboratories (NYSE:BIO) had its price target raised by analysts at Citigroup Inc. from $350.00 to $375.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank Of Canada from $387.00 to $409.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for BIO provided by MarketBeat